Report Detail
Global (United States, European Union and China) HER2（ErbB2）Antibodies Market Research Report 2019-2025
- RnM3379338 |
- 06 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of HER2（ErbB2）Antibodies is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for HER2（ErbB2）Antibodies.
This report studies the global market size of HER2（ErbB2）Antibodies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the HER2（ErbB2）Antibodies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bio-Techne (Novus Biologicals, LLC)
Thermo Fisher Scientific
BioVision, Inc.,
Cell Signaling Technology (CST)
Atlas Antibodies
Proteintech Group, Inc
Genentech Inc. (F. Hoffmann-La Roche Ltd.)
Novartis AG
Abnova Corporation
Pfizer, Inc.
InvivoGen
Celltrion, Inc.
Biocon Limited
Market Segment by Product Type
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the HER2（ErbB2）Antibodies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key HER2（ErbB2）Antibodies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of HER2（ErbB2）Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global HER2（ErbB2）Antibodies Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Trastuzumab
- 1.3.3 Lapatinib
- 1.3.4 Ado-trastuzumab emtansine
- 1.3.5 Pertuzumab
- 1.3.6 Everolimus
- 1.4 Market Segment by Application
- 1.4.1 Global HER2（ErbB2）Antibodies Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global HER2（ErbB2）Antibodies Market Size
- 2.1.1 Global HER2（ErbB2）Antibodies Revenue 2014-2025
- 2.1.2 Global HER2（ErbB2）Antibodies Sales 2014-2025
- 2.2 HER2（ErbB2）Antibodies Growth Rate by Regions
- 2.2.1 Global HER2（ErbB2）Antibodies Sales by Regions 2014-2019
- 2.2.2 Global HER2（ErbB2）Antibodies Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 HER2（ErbB2）Antibodies Sales by Manufacturers
- 3.1.1 HER2（ErbB2）Antibodies Sales by Manufacturers 2014-2019
- 3.1.2 HER2（ErbB2）Antibodies Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 HER2（ErbB2）Antibodies Revenue by Manufacturers (2014-2019)
- 3.2.2 HER2（ErbB2）Antibodies Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global HER2（ErbB2）Antibodies Market Concentration Ratio (CR5 and HHI)
- 3.3 HER2（ErbB2）Antibodies Price by Manufacturers
- 3.4 Key Manufacturers HER2（ErbB2）Antibodies Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into HER2（ErbB2）Antibodies Market
- 3.6 Key Manufacturers HER2（ErbB2）Antibodies Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Trastuzumab Sales and Revenue (2014-2019)
- 4.1.2 Lapatinib Sales and Revenue (2014-2019)
- 4.1.3 Ado-trastuzumab emtansine Sales and Revenue (2014-2019)
- 4.1.4 Pertuzumab Sales and Revenue (2014-2019)
- 4.1.5 Everolimus Sales and Revenue (2014-2019)
- 4.2 Global HER2（ErbB2）Antibodies Sales Market Share by Type
- 4.3 Global HER2（ErbB2）Antibodies Revenue Market Share by Type
- 4.4 HER2（ErbB2）Antibodies Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global HER2（ErbB2）Antibodies Sales by Application
6 United States
- 6.1 United States HER2（ErbB2）Antibodies Breakdown Data by Company
- 6.2 United States HER2（ErbB2）Antibodies Breakdown Data by Type
- 6.3 United States HER2（ErbB2）Antibodies Breakdown Data by Application
7 European Union
- 7.1 European Union HER2（ErbB2）Antibodies Breakdown Data by Company
- 7.2 European Union HER2（ErbB2）Antibodies Breakdown Data by Type
- 7.3 European Union HER2（ErbB2）Antibodies Breakdown Data by Application
8 China
- 8.1 China HER2（ErbB2）Antibodies Breakdown Data by Company
- 8.2 China HER2（ErbB2）Antibodies Breakdown Data by Type
- 8.3 China HER2（ErbB2）Antibodies Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World HER2（ErbB2）Antibodies Breakdown Data by Company
- 9.2 Rest of World HER2（ErbB2）Antibodies Breakdown Data by Type
- 9.3 Rest of World HER2（ErbB2）Antibodies Breakdown Data by Application
- 9.4 Rest of World HER2（ErbB2）Antibodies Breakdown Data by Countries
- 9.4.1 Rest of World HER2（ErbB2）Antibodies Sales by Countries
- 9.4.2 Rest of World HER2（ErbB2）Antibodies Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bio-Techne (Novus Biologicals, LLC)
- 10.1.1 Bio-Techne (Novus Biologicals, LLC) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.1.4 HER2（ErbB2）Antibodies Product Introduction
- 10.1.5 Bio-Techne (Novus Biologicals, LLC) Recent Development
- 10.2 Thermo Fisher Scientific
- 10.2.1 Thermo Fisher Scientific Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.2.4 HER2（ErbB2）Antibodies Product Introduction
- 10.2.5 Thermo Fisher Scientific Recent Development
- 10.3 BioVision, Inc.,
- 10.3.1 BioVision, Inc., Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.3.4 HER2（ErbB2）Antibodies Product Introduction
- 10.3.5 BioVision, Inc., Recent Development
- 10.4 Cell Signaling Technology (CST)
- 10.4.1 Cell Signaling Technology (CST) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.4.4 HER2（ErbB2）Antibodies Product Introduction
- 10.4.5 Cell Signaling Technology (CST) Recent Development
- 10.5 Atlas Antibodies
- 10.5.1 Atlas Antibodies Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.5.4 HER2（ErbB2）Antibodies Product Introduction
- 10.5.5 Atlas Antibodies Recent Development
- 10.6 Proteintech Group, Inc
- 10.6.1 Proteintech Group, Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.6.4 HER2（ErbB2）Antibodies Product Introduction
- 10.6.5 Proteintech Group, Inc Recent Development
- 10.7 Genentech Inc. (F. Hoffmann-La Roche Ltd.)
- 10.7.1 Genentech Inc. (F. Hoffmann-La Roche Ltd.) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.7.4 HER2（ErbB2）Antibodies Product Introduction
- 10.7.5 Genentech Inc. (F. Hoffmann-La Roche Ltd.) Recent Development
- 10.8 Novartis AG
- 10.8.1 Novartis AG Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.8.4 HER2（ErbB2）Antibodies Product Introduction
- 10.8.5 Novartis AG Recent Development
- 10.9 Abnova Corporation
- 10.9.1 Abnova Corporation Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.9.4 HER2（ErbB2）Antibodies Product Introduction
- 10.9.5 Abnova Corporation Recent Development
- 10.10 Pfizer, Inc.
- 10.10.1 Pfizer, Inc. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of HER2（ErbB2）Antibodies
- 10.10.4 HER2（ErbB2）Antibodies Product Introduction
- 10.10.5 Pfizer, Inc. Recent Development
- 10.11 InvivoGen
- 10.12 Celltrion, Inc.
- 10.13 Biocon Limited
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 HER2（ErbB2）Antibodies Sales Channels
- 11.2.2 HER2（ErbB2）Antibodies Distributors
- 11.3 HER2（ErbB2）Antibodies Customers
12 Market Forecast
- 12.1 Global HER2（ErbB2）Antibodies Sales and Revenue Forecast 2019-2025
- 12.2 Global HER2（ErbB2）Antibodies Sales Forecast by Type
- 12.3 Global HER2（ErbB2）Antibodies Sales Forecast by Application
- 12.4 HER2（ErbB2）Antibodies Forecast by Regions
- 12.4.1 Global HER2（ErbB2）Antibodies Sales Forecast by Regions 2019-2025
- 12.4.2 Global HER2（ErbB2）Antibodies Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on HER2（ErbB2）Antibodies . Industry analysis & Market Report on HER2（ErbB2）Antibodies is a syndicated market report, published as Global (United States, European Union and China) HER2（ErbB2）Antibodies Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of HER2（ErbB2）Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
